Last reviewed · How we verify
Placebo-Control
Placebo-Control is not an active pharmaceutical agent but rather an inert control substance used in clinical trials to establish baseline efficacy and safety comparisons.
At a glance
| Generic name | Placebo-Control |
|---|---|
| Sponsor | Theratechnologies |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo-Control serves as a comparator arm in randomized controlled trials, containing no active ingredient. It allows researchers to distinguish the true pharmacological effects of an investigational drug from placebo response, natural disease progression, and observer bias. This is a methodological tool rather than a therapeutic agent.
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease (NA)
- Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure (NA)
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases (PHASE3)
- Trial of Suvorexant for Sleep in Children With Autism (PHASE2)
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo-Control CI brief — competitive landscape report
- Placebo-Control updates RSS · CI watch RSS
- Theratechnologies portfolio CI